REG - Trellus Health PLC - Trellus IBD program launches on GI OnDEMAND

Trellus HealthAnnouncement

19/10/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221019:nRSS3299Da&default-theme=true

RNS Number : 3299D  Trellus Health PLC  19 October 2022

 

Trellus Health plc

("Trellus Health" or the "Company")

 

Trellus IBD program launches on GI OnDEMAND

 

Partnership with leading GI virtual integrated care platform enables US gastroenterology practices
 to deliver coordinated and personalized behavioral and nutritional support for IBD Patients

 

LONDON, U.K. AND NEW YORK, U.S. (19 October 2022): Trellus Health plc (AIM:
TRLS), which is commercializing a scientifically validated, personalized
resilience-driven self-management solution for chronic health conditions at
their intersection with mental health, announces that the Trellus Resilience
Training and Self-Management Solution for Inflammatory Bowel Disease (the
"Trellus IBD program") is now available on GI OnDemand, gastroenterology's
leading multidisciplinary virtual integrated care platform.

 

GI OnDEMAND, a joint venture between the American College of Gastroenterology
("ACG") and Gastro Girl, Inc., now offers the Trellus IBD program, to all GI
OnDEMAND and ACG members nationwide to coordinate and deliver personalized
behavioral, emotional and nutritional support for their IBD patients remotely
via digital solutions, and access to an expert resilience team via telehealth.
The Trellus IBD program will be the only resilience driven self-management
training solution offered via this platform to over 16,000 gastrointestinal
("GI") professionals across the US for the benefit of the millions of patients
they collectively serve.

 

ACG champions the prevention, diagnosis, and treatment of digestive disorders,
serving to guide the delivery of the highest quality, compassionate and
evidence-based patient care. It seeks to enhance the ability of its members to
provide world class care to patients with digestive disorders and advance the
profession through excellence and innovation.

 

The partnership with GI OnDEMAND forms a key part of Trellus Health's strategy
to expand access to its self-management solution through multiple channels,
including via healthcare providers and directly to patients, and is expected
to prove to be a key channel to market for accessing D2C customers. Trellus
Health intends to leverage the data generated on expected improvements in
outcomes and on reductions in the cost of caring for GI patients, to support
the wider rollout of its solution to both private and nationally funded
healthcare payers.

 

Jacqueline Gaulin, Founder, Chief Strategy Officer, Gastro Girl/GI OnDEMAND
said: "Our partnership with Trellus Health reflects a mutual passion for
taking a multidisciplinary approach to patient care and an unwavering mission
to make digestive health expertise, resources and support accessible to
everyone. We look forward to working together with the Trellus team to further
expand the awareness and reach of the Trellus IBD program so all patients with
IBD have access to this personalized and evidence-based program that gives
them the tools and the team to better manage their health and live well
physically, emotionally and socially."

 

William Chey, MD, FACG, Chief, Division of Gastroenterology & Hepatology,
Michigan Medicine and Senior Director, Nutrition and Behavioral Health
Services, GI OnDEMAND, said: "GI OnDEMAND expands a provider's ability to
deliver a first-in-class patient self-management solution for IBD. All of our
members' patients can now have access to a digitally delivered, resilience
based, self-management training program developed and validated at Mount Sinai
(NY) to enable them to take charge of their health needs, access behavioral
and emotional support in between office visits, and to experience better
outcomes. This is exactly what our GI patients need."

 

Dr. Marla Dubinsky, Chief Executive Officer of Trellus Health, said: "I am
delighted to launch our partnership with GI OnDemand which adds another
significant growth channel under our D2C model to support the
commercialization of the Trellus IBD Self-management Program. We will be the
only resilience training solution offered to this network of over 16,000 US
based GI professionals and alongside our licensing agreement with the Crohn's
and Colitis Foundation, the largest patient advocacy group for IBD in the US,
we have already established the broadest possible reach into the US
gastroenterological community, to access both patients and GI providers
nationwide."

 

About the Trellus IBD program

Trellus Health is pioneering a scientifically validated, personalized
resilience-driven self-management solution for chronic health conditions which
addresses the intersection of chronic illness with mental health, estimated to
cost the US economy $3.7 trillion annually.(1) The Trellus approach transforms
chronic condition management and changes the lives of patients living with
debilitating, incurable conditions, initially focused on IBD, including
Crohn's Disease and ulcerative colitis, and shortly IBS, but with potential
utility and demand across many chronic conditions.

 

The Trellus IBD program is a self-management solution driven by personalized
resilience training. The program empowers and enables members to manage their
condition by teaching them to set goals, actively identify challenges and
solve problems associated with their condition, driving a change of health
behavior to deliver improved outcomes and health status at lower cost.

 

Patients with IBD face many challenges which are common across many chronic
conditions: the management of complex medication regimens, dealing with
symptoms and disability, monitoring physical indicators, maintaining proper
levels of nutrition, adjusting to the psychological and social demands
including difficult lifestyle adjustments, as well as engaging in effective
interactions with health providers.

 

Trellus's personalized resilience-driven self-management training programs are
designed specifically for people looking to overcome these challenges. The aim
is to provide better quality patient outcomes at a lower cost to health plans
and employers, and the proprietary resilience method has been proven to reduce
unplanned hospitalizations by 94% at the Mount Sinai IBD Center, New York,
NY.(2)

 

For further information please contact:

 

 Trellus Health plc                                       www.trellushealth.com (http://www.trellushealth.com)
 Julian Baines, Chairman                                  Via Walbrook PR

 Singer Capital Markets (Nominated Adviser & Broker)      Tel: 020 7496 3000
 Aubrey Powell / Jen Boorer

 Walbrook PR Limited                                      Tel: 020 7933 8780 or trellus@walbrookpr.com (mailto:trellus@walbrookpr.com)
 Paul McManus / Sam Allen / Phillip Marriage              Mob: 07980 541 893 / 07748 651 727 / 07867 984 082

 

 

About Trellus Health plc (www.trellushealth.com (http://www.trellushealth.com)
)

Trellus Health (LSE: TRLS) is the first resilience based digital health
company focused on the intersection of chronic illness and mental health.
Trellus Health integrates its proprietary resilience-based methodology with
the technology, tools and team to deliver a whole-person technology-enhanced
experience that results in relieving disease burden, building self-management
skills and promoting individual health behaviors that enable thriving in the
face of a chronic condition. Through its TrellusElevate™ connected health
platform and companion App, the company addresses both physical and behavioral
health together, in context, to improve outcomes and reduce healthcare costs
across the healthcare ecosystem.

 

The Company is initially focused on Inflammatory bowel disease ("IBD"), which
includes the chronic incurable conditions of Crohn's Disease and ulcerative
colitis, and shortly Irritable Bowel Syndrome ("IBS"), but, given the common
struggles of self-management, considers its approach to have potential utility
and demand across many chronic conditions.

 

The TrellusElevate™ platform is the Company's proprietary connected health
platform that incorporates the GRITT™ methodology and learnings on
resilience from clinical research and practice conducted at the Mount Sinai
IBD Center for more than five years. This proprietary, resilience-driven
methodology has been scientifically validated to demonstrate meaningful
improvements in patient outcomes, 71% reduction in Emergency Department
(A&E) visits, and 94% reduction in unplanned hospitalisations, which the
directors of the Company believe indicates the potential for significant cost
savings for healthcare payers. Patients with IBD treated using the methodology
also experienced a 49% reduction in required opioid use and a 73% reduction in
corticosteroid use 12 months following starting the program(2).

 

The Company was founded by Mount Sinai faculty members Marla C. Dubinsky, MD
and Laurie Keefer, PhD, both with decades of combined experience in IBD and
psychogastroenterology, respectively. Trellus Health's patent-pending GRITT™
resilience assessment and personalized resilience training methodology was
developed and validated at the Mount Sinai Health System to build resilience
and wellness for improved outcomes at lower cost.

 

Shares in Trellus Health were admitted to trading on AIM in May 2021, under
the ticker TRLS. For more information on Trellus Health, visit:
www.trellushealth.com (http://www.trellushealth.com)

 

1) Source: https://www.cdc.gov/chronicdisease/about/costs/index.htm
(https://urldefense.proofpoint.com/v2/url?u=https-3A__www.cdc.gov_chronicdisease_about_costs_index.htm&d=DwMFaQ&c=euGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM&r=fSst1AtlXyuqcs3cHJXcCRilbI1Qm1WfjNYkVgQfiLE&m=IjQVBqsF0mJCc4cCch3kNewShI3X349VlYSUrh3C5-c&s=lilxcTv-hIGGEbeSix8wsDKl8TOyuP3Vw__GebvZFro&e=)
)

2) Source: https://www.sciencedirect.com/science/article/pii/S1542356521012258
(https://www.sciencedirect.com/science/article/pii/S1542356521012258) ).

 

About
GI OnDEMAND (http://giondemand.com/)

® (http://giondemand.com/)

GI OnDEMAND is a joint venture between the American College of
Gastroenterology (ACG) and Gastro Girl, Inc. As gastroenterology's leading
multidisciplinary virtual care platform, GI OnDEMAND brings the full-ecosystem
of GI experts, resources and support together for GI clinicians and patients.
GI OnDEMAND makes it easier for GI practices to adopt a virtual integrated
care model and amplify the expertise and value the practice brings to patients
with access to vetted GI expert registered dietitians, GI psychologists, as
well as genetic testing and expert genetic counselling. GI OnDEMAND also
features telehealth capabilities, access to evidence-based educational
programs.

 

About the American College of Gastroenterology Founded in 1932, the American
College of Gastroenterology (ACG) is an organization with an international
membership of over 17,000 individuals from 86 countries. The College's vision
is to be the preeminent professional organization that champions the
prevention, diagnosis, and treatment of digestive disorders, serving as a
beacon to guide the delivery of the highest quality, compassionate, and
evidence-based patient care. The mission of the College is to enhance the
ability of our members to provide world class care to patients with digestive
disorders and advance the profession through excellence and innovation based
upon the pillars of Patient Care, Education, Scientific Investigation,
Advocacy and Practice Management. www.gi.org (http://www.gi.org)

 

About Gastro Girl

Gastro Girl, Inc., is a patient-centric health company that empowers
individuals to achieve optimal digestive health. Since 2016 Gastro Girl has
served as the official patient education partner of The American College of
Gastroenterology (ACG).  Gastro Girl and ACG expanded this partnership in
2019 to make digestive health expertise, resources and support available to
everyone via GI OnDEMAND. In addition to connecting patients to GI experts-
including gastroenterologists, registered dietitians, and psychologists via GI
OnDEMAND, Gastro Girl delivers actionable and evidence-based health
information and resources to help everyone achieve better health, including
the Gastro Girl Podcast.  gastrogirl.com (https://gastrogirl.com/)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCUWRRRUVURAUA